Central imidazoline receptors and centrally acting anti-hypertensive agents

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 591-605

  Head, Geoffrey A ^a   Burke, Sandra L ^a   Chan, Candy K S ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Blood pressure; Clonidine; Efaroxan; Idazoxan; Imidazoline receptors; Methyldopa; Moxonidine 2 Adrenoceptors; Rabbits; Renal sympathetic baroreflexes; Rilmenidine; Rostral ventrolateral medulla oblongata

Indexed keywords

ANTIHYPERTENSIVE AGENT; CLONIDINE; EFAROXAN; IDAZOXAN; METHYLDOPA; RILMENIDINE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRESSORECEPTOR REFLEX; RABBIT;

EID: 0030861739     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083172     Document Type: Conference Paper

References (17)

1. Bousquet, P., Feldman, J., Schwartz, J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther. 1984; 230: 232-236.
2. Ernsberger, P., Guiliano, R., Willette, R.N., Reis, D.J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther. 1990; 253: 408-418.
3. Head, G.A., Korner, P.I., Lewis, S.L., Badoer, E. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and α-methyldopa in rabbits. J Cardiovasc Pharmacol. 1983; 5: 945-953.
4. Head, G.A., Burke, S.L. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine. J Cardiovasc Pharmacol. 1991; 18: 819-826.
5. Punnen, S., Urbanski, R., Krieger, A.J., Sapru, H.N. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 1987; 422: 336-346.
6. Lipski, J., Przybylski, J., Solnicka, E. Reduced hypotensive effect of clonidine after lesions of the nucleus tractus solitarii in rats. Eur J Pharmacol. 1976; 38: 19-22.
7. Dorward, P.K., Riedel, W., Burke, S.L., Gipps, J., Korner, P.I. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res. 1985; 57: 618-633.
8. Malpas, S.C., Shweta, A., Anderson, W.P.A, Head, G.A. Graded increases in renal nerve activity with hypoxia in conscious rabbits: renal nerve activity and excretory responses. Am J Physiol. (in press).
9. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Tibirica, E., Belcourt, A., Bousquet, P. Rilmenidine selectivity for imidazoline receptors in human brain. Eur J Pharmacol. 1989; 163: 373-377.
10. Sannajust, F., Head, G.A. Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors. J Cardiovasc Pharmacol. 1994; 23: 42-50.
11. Head, G.A., Sannajust, F. Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits. Fundam Clin Pharmacol. 1992; 6 (suppl 1): 31s-43s.
12. Head, G.A., Godwin, S.J., Sannajust, F. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J Hypertens. 1993; 11 (suppl. 5): S322-S323.
13. 1-imidazoline receptors. J Cardiovasc Pharmacol. 1992; 20 (suppl. 4): S1-S10.
14. Chan, C.K.S., Head, G.A. Relative importance of central imidazoline receptors for the anti-hypertensive effects of moxonidine and rilmenidine. J Hypertens. 1996; 14: 855-864.
15. Sannajust, F., Head, G.A. Effect of rilmenidine on the baroreflex control of renal sympathetic nerve activity. J Hypertens. 1993; 11 (suppl.5): S328-S329.
16. Head, G.A. Central monoamine systems and new antihypertensive agents. Clin Exp Hypertens. 1995; 17: 141-152.
17. 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine. J Cardiovasc Pharmacol. 1990; 16: 15-22.